Physician profile
Karen E Coblens
NPI 1063479848
$3,868.17
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,651 · 2020: $593 · 2021: $18.10 · 2022: $606.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $564.70 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $510.53 | 2019-2022 | |
| Novo Nordisk INC | $487.02 | 2019-2020 | |
| Pfizer INC. | $389.31 | 2019-2020 | |
| Glaxosmithkline, LLC. | $218.00 | 2019 | |
| Merck Sharp & Dohme LLC | $214.40 | 2019-2020 | |
| Amarin Pharma, INC. | $189.60 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $183.78 | 2019-2020 | |
| Boston Scientific Corporation | $147.04 | 2022 | |
| Sanofi-Aventis U.S. LLC | $114.01 | 2019 | |
| Astellas Pharma US INC | $99.95 | 2019 | |
| Allergan, INC. | $99.50 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $94.18 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.61 | 2019-2020 | |
| Amgen INC. | $87.86 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $84.67 | 2019-2020 | |
| Medtronic Vascular, INC. | $61.20 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.16 | 2019 | |
| Daiichi Sankyo INC. | $47.41 | 2019 | |
| Sanofi Pasteur INC. | $44.76 | 2019-2020 | |
| Genentech USA, INC. | $34.66 | 2019-2020 | |
| Therapeuticsmd, INC. | $30.89 | 2019 | |
| Qiagen, LLC | $15.93 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Coblens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.